Skip to main content

Basel Medical Group Ltd

BMGL
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0002004489

No open-market purchases or sales by Basel Medical Group Ltd insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $3.44K in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Basel Medical Group Ltd changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of BMGL: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders104−6
Shares143.3K53.9K−89.4K (−62.4%)
Value$70.2K$32.2K−$38.0K (−54.1%)

New holders (1)

Institutions that held Basel Medical Group Ltd at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to BMGL in Q1 2026
InstitutionSharesValue% of portfolio
T3 Companies, LLC15,000$8.85K0.01%

Sold out (7)

Institutions that held Basel Medical Group Ltd at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of BMGL in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Ground Swell Capital, LLC33,705$16.5K
Citadel Advisors LLC24,672$12.1K
Jane Street Group, LLC16,288$7.98K
Susquehanna International Group, LLP15,290$7.49K
Renaissance Technologies LLC14,498$7.10K
Bell Investment Advisors, Inc248$122
Citigroup Inc1$0